BioInsights - Home page

CELL & GENE THERAPY INSIGHTS

March 2023 Issue

Vol 9 Issue 2

Cell Therapy Materials & Upstream Processing/Analytics

Featuring this month's spotlight content:

Cell Therapy Materials & Upstream Processing/Analytics
View
Cryopreservation & Cold Chain

Supply Chain focus:

Cryopreservation & Cold Chain
View
Cell & Gene Therapy Insights Vol 9 Issue 2
View

Upcoming webinars

Overcoming challenges to succeed when transitioning into a cGMP environment

Overcoming challenges to succeed when transitioning into a cGMP environment

Kris Wronski
30 March 2023
in 1
Days
Register
Chromatographic modalities, buffer selection and other considerations for enrichment of AAV product

Chromatographic modalities, buffer selection and other considerations for enrichment of AAV product

Rok Žigon
5 April 2023
in 7
Days
Register
Cell therapy manufacturing and 21 CFR Part 11 compliance: Overview and considerations for instrument software

Cell therapy manufacturing and 21 CFR Part 11 compliance: Overview and considerations for instrument software

Ashley Smith, Brianna Volk
6 April 2023
in 8
Days
Register
De-risking lentiviral vector production using a robust, scalable, suspension-based platform

De-risking lentiviral vector production using a robust, scalable, suspension-based platform

Jimmy Xin
11 April 2023
in 13
Days
Register
Skip the hassle for AAV and AdV empty/full and titer data with Stunner

Skip the hassle for AAV and AdV empty/full and titer data with Stunner

Nelis Denys
12 April 2023
in 14
Days
Register
Navigating bottlenecks in cell therapy manufacturing: A versatile and scalable platform solution

Navigating bottlenecks in cell therapy manufacturing: A versatile and scalable platform solution

Peter Yates
13 April 2023
in 15
Days
Register
View all webinars

Latest Articles

Funding the future: cell & gene therapy development

Funding the future: cell & gene therapy development

Nick Meyers, Neil Fish
27 March 2023
Viewpoint
Investing long-term in the cell & gene therapies of the future

Investing long-term in the cell & gene therapies of the future

Geeta Vemuri
26 March 2023
Interview
Challenges in cryogenic storage containers for cell & gene therapy

Challenges in cryogenic storage containers for cell & gene therapy

Sean Werner, Alex Sargent
26 March 2023
Podcast
Ultra-rapid microbial detection in cell & gene therapy products: the closest you can be to real-time release

Ultra-rapid microbial detection in cell & gene therapy products: the closest you can be to real-time release

Félix Montero-Julian
26 March 2023
FastFacts
Challenges in obtaining cellular therapy starting material for patients with sickle cell disease

Challenges in obtaining cellular therapy starting material for patients with sickle cell disease

Yvette C Tanhehco
22 March 2023
Expert Insight
Establishing an end-to-end vector manufacturing solution for the gene therapy industry

Establishing an end-to-end vector manufacturing solution for the gene therapy industry

Nicole Faust
21 March 2023
Interview
Exosome production process development in stirred-tank bioreactors

Exosome production process development in stirred-tank bioreactors

Stefan Schlößer
21 March 2023
FastFacts
Taking lessons from nature to improve cell therapy cryopreservation

Taking lessons from nature to improve cell therapy cryopreservation

J Acker, N William, M Coatham
20 March 2023
Expert Insight
Exploring the potential of insect cell lines for efficient AAV production

Exploring the potential of insect cell lines for efficient AAV production

Tsuyoshi Teshima, Mai Sasaki
20 March 2023
Interview

Channel content

Ultra-rapid microbial detection in cell & gene therapy products: the closest you can be to real-time release

Ultra-rapid microbial detection in cell & gene therapy products: the closest you can be to real-time release

Félix Montero-Julian
26 March 2023
FastFacts
mRNA manufacturing and analytics: INFOGRAPHIC

mRNA manufacturing and analytics: INFOGRAPHIC

20 March 2023
Infographic
Lentiviral titer determination: rapid & robust molecular methods suitable for validation

Lentiviral titer determination: rapid & robust molecular methods suitable for validation

Unnati Dev
15 March 2023
Webinar Digest
View channel
Challenges in cryogenic storage containers for cell & gene therapy

Challenges in cryogenic storage containers for cell & gene therapy

Alex Sargent
26 March 2023
Podcast
Ultra-rapid microbial detection in cell & gene therapy products: the closest you can be to real-time release

Ultra-rapid microbial detection in cell & gene therapy products: the closest you can be to real-time release

Félix Montero-Julian
26 March 2023
FastFacts
Challenges in obtaining cellular therapy starting material for patients with sickle cell disease

Challenges in obtaining cellular therapy starting material for patients with sickle cell disease

Yvette C Tanhehco
22 March 2023
Expert Insight
View channel
Ultra-rapid microbial detection in cell & gene therapy products: the closest you can be to real-time release

Ultra-rapid microbial detection in cell & gene therapy products: the closest you can be to real-time release

Félix Montero-Julian
26 March 2023
FastFacts
Establishing an end-to-end vector manufacturing solution for the gene therapy industry

Establishing an end-to-end vector manufacturing solution for the gene therapy industry

Nicole Faust
21 March 2023
Interview
mRNA manufacturing and analytics: INFOGRAPHIC

mRNA manufacturing and analytics: INFOGRAPHIC

20 March 2023
Infographic
View channel
Ultra-rapid microbial detection in cell & gene therapy products: the closest you can be to real-time release

Ultra-rapid microbial detection in cell & gene therapy products: the closest you can be to real-time release

Félix Montero-Julian
26 March 2023
FastFacts
Seizing the day: addressing the urgent need for standards development in regenerative medicine

Seizing the day: addressing the urgent need for standards development in regenerative medicine

Richard McFarland
15 March 2023
Interview
Overcoming challenges to CAR-T cell therapies in India

Overcoming challenges to CAR-T cell therapies in India

A Uppal, R Chakrabarti, N Chirmule et al.
8 March 2023
Commentary
View channel
Challenges in cryogenic storage containers for cell & gene therapy

Challenges in cryogenic storage containers for cell & gene therapy

Alex Sargent
26 March 2023
Podcast
Challenges in obtaining cellular therapy starting material for patients with sickle cell disease

Challenges in obtaining cellular therapy starting material for patients with sickle cell disease

Yvette C Tanhehco
22 March 2023
Expert Insight
Taking lessons from nature to improve cell therapy cryopreservation

Taking lessons from nature to improve cell therapy cryopreservation

J Acker, N William, M Coatham
20 March 2023
Expert Insight
View channel
Preclinical safety assessment in therapeutic genome editing

Preclinical safety assessment in therapeutic genome editing

Roberto Nitsch
10 March 2023
Viewpoint
Addressing gene therapy translational R&D bottlenecks in the CNS

Addressing gene therapy translational R&D bottlenecks in the CNS

Anindya Sen
9 March 2023
Viewpoint
Current trends in advanced therapy development & commercialization for rare diseases

Current trends in advanced therapy development & commercialization for rare diseases

Alan Boyd
28 February 2023
Viewpoint
View channel
Funding the future: cell & gene therapy development

Funding the future: cell & gene therapy development

Nick Meyers, Neil Fish
27 March 2023
Viewpoint
Overcoming challenges to CAR-T cell therapies in India

Overcoming challenges to CAR-T cell therapies in India

A Uppal, R Chakrabarti, N Chirmule et al.
8 March 2023
Commentary
Distributed manufacturing models for ATMPs: can they work: do we understand the pitfalls?

Distributed manufacturing models for ATMPs: can they work: do we understand the pitfalls?

Mark Lowdell
2 March 2023
Viewpoint
View channel